文献速递外周动脉疾病

糖化血红蛋白对下肢旁路术后结局的影响

The impact of hemoglobin A1c on outcomes after lower extremity bypass.
PubMed 文献 · J Vasc Surg · 2020-07-28

基于血管质量倡议数据库(2007-2018)8171例因慢性肢体威胁性缺血行腹股沟下下肢旁路术的病例,按围术期HbA1c分为<5.7%、5.7%-6.5%和>6.5%三组并进行倾向评分匹配。结果显示HbA1c升高与伤口感染及围术期死亡无显著关联,但较低的HbA1c与死亡率升高相关。

要点

  • HbA1c水平与下肢旁路术后伤口感染无显著关联。
  • HbA1c>6.5%与<5.7%相比围术期死亡无差异,但校正分析中较低HbA1c与更高死亡风险相关。
  • 需进一步研究短期血糖控制对下肢旁路术患者长期结局的影响。

核心结论

  • 研究提示HbA1c升高与下肢旁路术围术期并发症无显著关联。
  • 需进一步评估短期血糖控制及下肢旁路术患者长期结局的影响。

研究设计与样本

  • 回顾性队列研究,使用血管质量倡议数据库2007-2018年数据。
  • 纳入8171例因慢性肢体威胁性缺血行腹股沟下下肢旁路术的连续病例。
  • 按围术期HbA1c分层为<5.7%、5.7%-6.5%和>6.5%,并对人口学、病史和手术特征进行倾向评分匹配。

主要发现

  • CLTI队列伤口感染率:HbA1c<5.7%为3.8%,5.7%-6.5%为3.7%,>6.5%为3.2%(P = .53)。
  • 匹配队列伤口感染率分别为4.3%、4.5%、3.4%(P = .62)。
  • CLTI队列围术期死亡率分别为2.5%、1.7%、1.5%(P = .16),匹配队列为2.7%、2.3%、2.2%(P = .84)。
  • 多变量分析中HbA1c与伤口感染无显著关联:5.7%-6.5% vs <5.7%的aOR为0.91(95%CI 0.56-1.50,P = .72),>6.5% vs <5.7%的aOR为0.81(95%CI 0.52-1.26,P = .35)。
  • HbA1c降低与死亡率存在显著关联:5.7%-6.5% vs <5.7%的aHR为0.77(95%CI 0.61-0.97,P = .03),>6.5% vs <5.7%的aHR为0.75(95%CI 0.61-0.93,P = .01)。

关键数值与推荐

  • HbA1c分层界值为<5.7%、5.7%-6.5%、>6.5%。
  • CLTI队列各组例数:<5.7%为631例(7.7%),5.7%-6.5%为1691例(20.6%),>6.5%为5849例(71.6%)。

临床怎么用

  • 围术期HbA1c升高不应单独作为下肢旁路术后伤口感染或围术期死亡的预判依据。
  • 对HbA1c较低的患者应关注其死亡风险,并结合整体状况评估围术期管理。

局限性

  • 为回顾性数据库研究,可能存在未测量混杂。
  • 仅评估围术期HbA1c,未充分反映短期血糖控制与长期结局的关系。
  • 作者指出需进一步研究以评估短期血糖控制及长期结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Diabetes has been shown to be associated with increased risk of postoperative complications after lower extremity bypass (LEB), although it is unclear whether medium-term glucose control affects outcomes. This study aimed to assess the association of perioperative hemoglobin A1c (HbA1c) level on perioperative outcomes after LEB. METHODS: We examined consecutive infrainguinal LEBs for chronic limb-threatening ischemia (CLTI) using the Vascular Quality Initiative database (2007-2018). Perioperative HbA1c levels were stratified into <5.7%, 5.7% to 6.5%, and >6.5%. Propensity score matching on demographics, medical history, and procedural characteristics was used to select comparable patients across HbA1c groups. The primary outcome was postoperative wound infection. Multivariable analyses were performed for matched and unmatched groups using Cox proportional hazards models for survival outcomes and logistic regression for binary outcomes with association expressed by adjusted hazard ratio (aHR) or adjusted odds ratio (aOR) and corresponding 95% confidence intervals (CIs). RESULTS: The CLTI cohort included 8171 infrainguinal LEBs: 631 (7.7%) had HbA1c <5.7%; 1691 (20.6%), 5.7% to 6.5%; and 5849 (71.6%), >6.5%. There was no difference in rates of wound infection in the CLTI cohort (HbA1c ≤5.7%, 3.8%; HbA1c 5.7%-6.5%, 3.7%; HbA1c >6.5%, 3.2%; P = .53) or matched cohort (4.3%, 4.5%, 3.4%; P = .62). There were no differences in perioperative mortality in the CLTI cohort (2.5%, 1.7%, 1.5%; P = .16) or the matched cohort (2.7%, 2.3%, 2.2%; P = .84). In multivariable analysis, there was no significant association between HbA1c and wound infection in the CLTI cohort (HbA1c 5.7%-6.5% vs <5.7%: aOR, 0.91 [95% CI, 0.56-1.50; P = .72]; HbA1c >6.5% vs <5.7%: aOR, 0.81 [95% CI, 0.52-1.26; P = .35]). There was, however, a significant association between decreased HbA1c and mortality (HbA1c 5.7%-6.5% vs <5.7%: aHR, 0.77 [95% CI, 0.61-0.97; P = .03]; HbA1c >6.5% vs <5.7%: aHR, 0.75 [95% CI, 0.61-0.93; P = .01]). CONCLUSIONS: Our study suggests no significant association of increased HbA1c level and perioperative complications. Additional investigation is required to further evaluate the impact of short-term glycemic control and long-term outcomes of patients undergoing LEB.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lee A, Haddad D, Rybin D, et al. The impact of hemoglobin A1c on outcomes after lower extremity bypass. J Vasc Surg. 2020. PMID: 32730894. doi:10.1016/j.jvs.2020.05.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。